ClinicalTrials.gg
CompletedNCT04211584TDRUpdated Nov 8, 2022

The TENDERA Multicenter Clinical Trial

An interventional study of transradial interventions in Artery; Thrombosis, sponsored by Center of Endosurgery and Lithotripsy, Moscow, Russia. Completed at 1 site in Russia. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2022-11-08.

Sponsored by Center of Endosurgery and Lithotripsy, Moscow, Russia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
850
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

TENDERA is a multicenter randomized controlled trial to compare traditional entry point in the radial artery for TRI and distal puncture at the anatomical snuffbox area for transradial Interventions. The Investigators hypothesized that novel entry point in radial artery may lessen vascular access site complication rate and especially the radial artery late occlusion rate.

Read the detailed description

the forearm access will be made using traditional technique what was well described previously in the literature. The novel puncture site is located in the snuffbox area distal to the traditional radial access point. Thanks to surrounded anatomical conditions in anatomical snuffbox area vascular access site complications may be lessened comparing to forearm radial access site.

02

Conditions studied

  • Artery; Thrombosis

Browse trials for

Keywords

  • Transradial intervention,radial artery,anatomic snuffbox
03

In context

Thrombosis

1,528 studies on the registry are indexed under Thrombosis; 240 are open to participants now.

This study's enrollment of 850 is above the median of 107 across 866 interventional studies indexed under Thrombosis.

Browse Thrombosis studies →

Lead sponsor

This is the only study on the registry with Center of Endosurgery and Lithotripsy, Moscow, Russia as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

age 18-75 primary radial artery puncture radial artery diameter >1,5mm by ultrasound stable coronary disease less than 6F sheath needed patient height >185cm

Exclusion criteria

Exclusion Criteria:

ACS AMI critically ill patients previous TRI procedure Raynaud's disease

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
850 participants (actual)

Study arms

  • Active comparator
    forearm radial artery access

    traditional access (puncture and cannulation) in the forearm part of the radial artery will be made for further coronary interventions

    Device: transradial interventions

  • Active comparator
    anatomic snuffbox access

    access in the snuffbox area of the wrist (puncture and cannulation) in the forearm part of the radial artery will be made for further coronary interventions

    Device: transradial interventions

Interventions

  • Devicetransradial interventions

    percutaneous coronary interventions in stable patients - diagnostic and treatment

06

What researchers measure

Primary outcomes

  1. Radial artery late occlusion

    loss of pulse or absent of artery lumen by ultrasound examonation

    Time frame: 1 year

Secondary outcomes

  1. vascular access site related complications

    hematomas \>5cm, bleeding, false aneurism, arterio-venous fistula

    Time frame: 1 week, 3 months, 6 moths, 1 year

07

Study locations

1 site
  • Center of Endosurgery
    Moscow, 111123, Russia
08

References and documents

Publications

  • Babunashvili AM, Pancholy S, Zulkarnaev AB, Kaledin AL, Kochanov IN, Korotkih AV, Kartashov DS, Babunashvili MA. Traditional Versus Distal Radial Access for Coronary Diagnostic and Revascularization Procedures: Final Results of the TENDERA Multicenter, Randomized Controlled Study. Catheter Cardiovasc Interv. 2024 Dec;104(7):1396-1405. doi: 10.1002/ccd.31271. Epub 2024 Oct 30. PubMed 39474765 ↗

Individual participant data

Plan to share: Yes — all IPD that underlie results

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: IV Q of 2021 after the end of the study

Access criteria: IPD may be requested by interventional cardiologists or radiologists IPD information may be shared after a request from individual or academic organizations if some concern and questions will raised

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 8, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04211584
Lead sponsor
Center of Endosurgery and Lithotripsy, Moscow, Russia
Responsible party
Sponsor
First posted
Dec 26, 2019
Start date
Dec 18, 2017
Primary completion
Sep 18, 2021
Completion
Oct 28, 2022
Last update
Nov 8, 2022

Study contacts

Avtandil M Babunashvili, MD
principal investigator · Center of Endosurgery
Alexander Kaledin, MD
principal investigator · North West state University Saint Petersburg

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion